Philogen SpA banner

Intrinsic Value

Is 78Q undervalued or overvalued?

See the intrinsic value estimate for Philogen SpA and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

78Q Intrinsic Value
LOCKED
Unlock
Today vs. history

78Q looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with 78Q’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor 78Q
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price €20.8
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 78Q

Fundamental Analysis

What Philogen SpA Does

Biotechnology Health Care

Philogen SpA is an Italian biotechnology company that develops cancer medicines and immune-based therapies. Its core idea is to attach a treatment to a molecule that homes in on diseased tissue, so the active drug can concentrate where it is needed most. The company also works on treatments for other serious inflammatory and autoimmune conditions, but oncology is its main focus.

Headquarters
Italy IT
Employees
214
IPO date
Mar 3, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Philogen SpA

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one 78Q stock?

The intrinsic value for Philogen SpA (78Q) under the Base Case is hidden EUR.

Is 78Q stock undervalued or overvalued?

Compared with the current market price of 20.8 EUR, the stock appears hidden.

Back to Top